RT @uptoTate: COAST-X: IXE met ASAS 40 and all secondary endpoints in nr-axSpA vs PBO. https://t.co/V0QNfi33eA #ACR19 @RheumNow plenary#272…

Social Author Image
https://pbs.twimg.com/profile_images/847812732007133184/hIbnEHt3.jpg
Tweet Author
uptoTate
Social Author Name
Dr. Rachel Tate
Tweet Content
COAST-X: IXE met ASAS 40 and all secondary endpoints in nr-axSpA vs PBO. https://t.co/V0QNfi33eA #ACR19 @RheumNow plenary#2729 #ACRbest https://t.co/VVkEfLpHzs
Links
Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Primary Results from a … http://ow.ly/KUY850x3EfF
Show on Archive Page
On
Display in Search Results
On

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×